Genetics Studies

Molecular docking appraisal of Dysphania ambrosioides phytochemicals as potential inhibitor of a key triple-negative breast cancer driver gene.

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer that lacks response to hormone therapy. There is a need for targeted molecular therapy for TNBC. The PI3K/AKT/mTOR signaling pathway plays a crucial role in TNBC, and AKT is a promising therapeutic target. In this study, researchers screened 25 compounds from a traditional herbal recipe for their anticancer properties. They found two compounds, cynaroside and epicatechin gallate, to be potent inhibitors of AKT 1 and 2 isoforms. These compounds demonstrate drug-like properties and show structural stability. Computational modeling suggests they could be effective drug candidates for TNBC, but further research is needed for clinical application.

Anifowose LO et al (2023).
In Silico Pharmacol.
PubMed:
37323538